Biocept CEO Michael Nall's 2020 pay jumps 47% to $1.8M
Biocept reports 2020 executive compensation
By ExecPay News
Published: April 30, 2021
Biocept reported fiscal year 2020 executive compensation information on April 30, 2021.
In 2020, three Biocept executives received on average a compensation package of $1.1M, a 37% increase compared to previous year.
Average pay of disclosed executives at Biocept
Michael W. Nall, Chief Executive Officer, received $1.8M in total, which increased by 47% compared to 2019. 59% of Nall's compensation, or $1M, was in option awards. Nall also received $235K in non-equity incentive plan, $495K in salary, as well as $9.5K in other compensation.
Timothy C. Kennedy, Chief Financial Officer, received a compensation package of $1.1M, which increased by 33% compared to previous year. 54% of the compensation package, or $596K, was in option awards.
Michael Terry, SVP Business Development, earned $515K in 2020.
Related executives
You may also like
Source: SEC filing on April 30, 2021.